398 related articles for article (PubMed ID: 30400384)
1. Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome.
Shinzawa M; Dogru M; Den S; Ichijima T; Higa K; Kojima T; Seta N; Nomura T; Tsubota K; Shimazaki J
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400384
[TBL] [Abstract][Full Text] [Related]
2. Salivary and Lacrimal Gland Alterations of the Epidermal Fatty Acid-Binding Protein (E-FABP) in Non-Obese Diabetic Mice.
Dogru M; Kojima T; Simsek C; Nagata T; Tsubota K
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408851
[TBL] [Abstract][Full Text] [Related]
3. Differential Diagnosis of Sjögren Versus Non-Sjögren Dry Eye Through Tear Film Biomarkers.
Akpek EK; Wu HY; Karakus S; Zhang Q; Masli S
Cornea; 2020 Aug; 39(8):991-997. PubMed ID: 32195754
[TBL] [Abstract][Full Text] [Related]
4. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
5. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
Kim M; Kim HS; Na KS
Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
[TBL] [Abstract][Full Text] [Related]
6. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
Yoon KC; Jeong IY; Park YG; Yang SY
Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients Under Desiccating Stress.
López-Miguel A; Tesón M; Martín-Montañez V; Enríquez-de-Salamanca A; Stern ME; González-García MJ; Calonge M
Am J Ophthalmol; 2016 Jan; 161():133-41.e1-2. PubMed ID: 26456254
[TBL] [Abstract][Full Text] [Related]
9. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity.
Begley CG; Chalmers RL; Abetz L; Venkataraman K; Mertzanis P; Caffery BA; Snyder C; Edrington T; Nelson D; Simpson T
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4753-61. PubMed ID: 14578396
[TBL] [Abstract][Full Text] [Related]
10. Proteomic and histopathological characterisation of sicca subjects and primary Sjögren's syndrome patients reveals promising tear, saliva and extracellular vesicle disease biomarkers.
Aqrawi LA; Galtung HK; Guerreiro EM; Øvstebø R; Thiede B; Utheim TP; Chen X; Utheim ØA; Palm Ø; Skarstein K; Jensen JL
Arthritis Res Ther; 2019 Jul; 21(1):181. PubMed ID: 31366407
[TBL] [Abstract][Full Text] [Related]
11. Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients.
Liang H; Kessal K; Rabut G; Daull P; Garrigue JS; Melik Parsadaniantz S; Docquier M; Baudouin C; Brignole-Baudouin F
Ocul Surf; 2019 Jul; 17(3):516-525. PubMed ID: 30905840
[TBL] [Abstract][Full Text] [Related]
12. Abnormal protein profiles in tears with dry eye syndrome.
Ohashi Y; Ishida R; Kojima T; Goto E; Matsumoto Y; Watanabe K; Ishida N; Nakata K; Takeuchi T; Tsubota K
Am J Ophthalmol; 2003 Aug; 136(2):291-9. PubMed ID: 12888052
[TBL] [Abstract][Full Text] [Related]
13. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system.
Szalai E; Berta A; Szekanecz Z; Szûcs G; Módis L
Cornea; 2012 Aug; 31(8):867-71. PubMed ID: 22580437
[TBL] [Abstract][Full Text] [Related]
15. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic significance of Fourier-domain optical coherence tomography in Sjögren syndrome, aqueous tear deficiency and lipid tear deficiency patients.
Qiu X; Gong L; Lu Y; Jin H; Robitaille M
Acta Ophthalmol; 2012 Aug; 90(5):e359-66. PubMed ID: 22568661
[TBL] [Abstract][Full Text] [Related]
17. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
[TBL] [Abstract][Full Text] [Related]
18. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
[TBL] [Abstract][Full Text] [Related]
19. Tear lipocalin and lysozyme in Sjögren and non-Sjögren dry eye.
Caffery B; Joyce E; Boone A; Slomovic A; Simpson T; Jones L; Senchyna M
Optom Vis Sci; 2008 Aug; 85(8):661-7. PubMed ID: 18677232
[TBL] [Abstract][Full Text] [Related]
20. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
